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Abstract
Purpose Gametocyte-specific factor 1 has been shown in oth-
er species to be required for the silencing of retrotransposons
via the Piwi-interacting RNA (piRNA) pathway. In this study,
we aimed to isolate and assess expression of transcripts of the
gametocyte-specific factor 1 (GTSF1) gene in the human fe-
male germline and in preimplantation embryos.
Methods Complementary DNA (cDNA) libraries from hu-
man fetal ovaries and testes, human oocytes and preimplanta-
tion embryos and ovarian follicles isolated from an adult ovar-
ian cortex biopsy were used to as templates for PCR, cloning
and sequencing, and real time PCR experiments of GTSF1
expression.
Results GTSF1 cDNA clones that covered the entire coding
region were isolated from human oocytes and preimplantation
embryos. GTSF1mRNA expression was detected in archived
cDNAs from staged human ovarian follicles, germinal vesicle
(GV) stage oocytes, metaphase II oocytes, and morula and
blastocyst stage preimplantation embryos. Within the adult
female germline, expression was highest in GV oocytes.
GTSF1 mRNA expression was also assessed in human fetal
ovary and was observed to increase during gestation, from 8 to
21 weeks, during which time oogonia enter meiosis and pri-
mordial follicle formation first occurs. In human fetal testis,
GTSF1 expression also increased from 8 to 19 weeks.
Conclusions To our knowledge, this report is the first to de-
scribe the expression of the human GTSF1 gene in human
gametes and preimplantation embryos.
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Introduction
The analysis of genes that are expressed in murine germ cells
or whole ovaries has led to the identification of a novel gene,
gametocyte-specific factor 1 (Gtsf1), also known as the com-
putationally obtained undifferentiated and/or embryonic stem
cell-specific 110 gene (Cue110) [1–3]. Gtsf1 encodes a 167-
amino acid protein that is a member of the Uncharacterized
Protein Family 0224 (UPF0224).
Three recent reports have revealed that in Drosophila,
gametocyte-specific factor 1 (DmGTSF1), is essential for P-
element-induced wimpy testis (PIWI)-interacting RNA
(piRNA)-mediated transcriptional repression and histone
H3K9me3-mediated repression of transposons and their
neighboring genes in the ovary [4–6]. DmGTSF1 interacts
with Piwi via its C-terminal tail [4] and the two CHHC zinc-
Capsule The expression of transcripts of the human Gametocyte-
Specific Factor 1 (GTSF1) gene were assessed in fetal gonads, the female
germline and in preimplantation embryos.
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finger motifs within the DmGTSF1 protein are required for its
activity [5]. In the mouse, the Gtsf1 gene is essential for sper-
matogenesis and has been revealed to function in transposon
suppression in the mouse testes since increased expression of
the long interspersed nucleotide element (line 1) and the
intracisternal A-particle (IAP) retrotransposons were observed
to occur in Gtsf1-null male mice [7]. The same study showed
that Gtsf1-null male mice are sterile due to massive apoptosis
of their germ cells and the cessation of meiotic progression
before the zygotene stage. In humans, these observations are
reflected by the observation that the testes of high infertility
risk (HIR) cryptorchidism patients have reduced GTSF1 ex-
pression and corresponding over-expression of LINE1 (L1)
retrotransposons [8]. GTSF1 has also been identified as a bo-
vine spermatozoal transcript [9]. Elsewhere,GTSF1 transcript
expression has been observed to be up-regulated in certain
leukemias and in lymphomas [10–14].
The precise role of theGtsf1 gene in the mammalian female
germline is less clear since Gtsf1-null female mice were ob-
served to be fertile [7]. The expression ofGtsf1 transcripts has
been detected in adult mouse primordial and primary follicles,
whilst Gtsf1 protein has been detected in germ cell clusters
and primordial follicles in newborn ovaries and in the oocytes
of all follicle stages [3]. Significantly, Gtsf1 was identified
among the transcripts that were down-regulated in ovaries
from mice deficient for the Nobox gene [2, 3]. Whilst not
essential for fertility, a role for Gtsf1 is implied during oogen-
esis and/or early embryonic development since other genes,
with diverse functions during oogenesis, are also down-
regulated in Nobox-deficient mice [15].
To our knowledge, this is the first report to describe cloning
and expression analysis of GTSF1 transcripts in human fetal
ovaries and testis, adult human ovarian follicles, GVandmeta-
phase II oocytes, and in preimplantation embryos.
Materials and methods
Samples
Human fetal ovaries and testes were obtained with in-
formed consent, according to published methods [16].
Ethical approval was from the Lothian Research Ethics
Committee (study code LREC 08/S1101/1). Briefly, human
fetal gonads (gestations between 8 and 21 weeks) were
obtained following medical termination of pregnancy and
were subsequently snap-frozen and stored at −80 °C. RNA
was extracted using the Qiagen RNeasy Mini Kit (14 weeks
gestation onwards) or Qiagen RNeasy Micro Kit (8–
12 weeks gestation) (Qiagen, Crawley, UK) with 500 ng
RNA used for first-strand cDNA synthesis using the
Superscript Vilo Reverse Transcriptase Master Mix (Life
Technologies, Paisley, UK).
Methods for sample preparation of the cDNA libraries
from human ovarian follicles and oocytes used in the pres-
ent study were performed according to published methods
[17, 18]. An ovarian cortex biopsy was donated for re-
search by a 22-year-old woman attending Leeds General
Infirmary hospital for gynaecological surgery under an eth-
ically approved protocol as described [17]. Following har-
vest, the tissue was cryopreserved. Briefly, human ovarian
follicles were isolated from the frozen-thawed ovarian cor-
tex biopsy by dissection and staged according to size and
morphology. Samples were collected from primordial fol-
licles (n = 28), primordial/early primary follicles (n = 45),
and primary follicles (n = 7), through to secondary stage
follicles (n = 7). Diameters used for follicle staging were
primordial follicles 34–38 mm, early primary follicles
34–53 mm, primary follicles 52–62 mm, and secondary
follicles 62–86 mm. Mature metaphase II (MII) oocytes
and preimplantation embryos that were surplus to require-
ment for clinical treatment were donated for research by
patients attending the assisted conception unit at Leeds
Gene r a l I n f i rma ry (Lee d s , Un i t ed K ingdom) .
Additionally, germinal vesicle (GV)-stage oocytes and cu-
mulus and mural granulosa cells were harvested from non-
luteinised antral follicles of 5 mm diameter that were aspi-
rated from two patients during immature oocyte recovery
as part of an in vitro maturation program as detailed in the
protocol of Wynn et al. 1998 [19]. These oocytes and their
surrounding granulosa cells had not been exposed to hCG
prior to recovery. Cleavage stage embryos that were sur-
plus to the patients’ treatment needs were donated for re-
search following embryo transfer on day 2, post insemina-
tion. Blastocysts were generated in vitro after a further 3–
5 days of culture according to the methods detailed by
Houghton et al. 2002 and, Ghassemifar et al. 2003 [20,
21]. Additionally, Cryopreserved embryos which were sur-
plus to the patients’ treatment requirements were donated
for research under informed consent by couples attending
Bourn Hall Clinic (Cambridge, United Kingdom).
Cryopreserved embryos were thawed and cultured to the
blastocyst stage in the HFEA licensed research laboratories
in Leeds according to the methods of Houghton et al.
(2002) and, Ghassemifar et al. (2003) [20, 21]. In summa-
ry, both fresh and frozen-thawed, cleavage staged preim-
plantation embryos were individually cultured in 4 μl drop-
lets of Earle’s Balanced Salt Solution, supplemented with
1 mM glucose, 5 mM lactate, 0.47 mM sodium pyruvate,
0.5 % (v/v) human serum albumin (Zenalb 20; Bio Products
Laboratory), and amino acids at close-to-physiological
concentrations, as defined by Tay et al. 1997 [22], under
embryo tested mineral oil at 37 °C under 5 % CO2 in air. At
the end of culture, embryos were washed in Ca2+ and Mg2+
free phosphate buffered saline at 4 °C (Invitrogen, UK),
before being snap frozen in liquid nitrogen in 20 μl
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Dynal lysis buffer (Life Technologies, Ltd). All samples
were obtained after informed consent under ethically ap-
proved protocols at the LGI, which were licensed in the UK
by the Human Fertilisation and Embryology Authority.
Reverse transcription and cDNA amplification
Ovarian follicle samples, single embryos, and oocytes were
collected and lysed at 80 °C in Dynal lysis buffer (Life
Technologies, Ltd) and cDNA libraries were generated as pre-
viously described [23]. For the ovarian follicle samples as
used in Fig. 1a, amplified cDNAs were generated from (i)
pooled primordial follicles (n = 28), (ii) primordial/early pri-
mary follicles (n = 45), (iii) primary follicles (n = 7), and (iv),
secondary stage follicles (n = 7).
Messenger RNA was extracted from preimplantation
embryos with oligo-dT Dynabeads, and cDNAwas generated
using an adaptation of existing cDNA amplification
protocols, using 1 μg each of primer (primer 1: 5′-
aaacgacggccagtgaattgtaatacgactcactatagggcgct24-3′ and prim-
er 2: 5′-aagcagtggtatcaacgcagagtacgcggg-3′) and Superscript
II RNAseH- Reverse Transcriptase (Life Technologies, Ltd)
and associated reagents with incubation for 2 h at 42 °C. The
cDNAwas amplified by PCR using an additional 1 μg of each
primer, 2 μl 50× Advantage 2 Polymerase (BD Clontech), in a
thermal cycler for 32 cycles of 95 °C for 45 s, 65 °C for 6 min
45 s in a total volume of 50 μl.
Isolation of GTSF1 transcripts and expression analysis
Expression analysis forGTSF1was performed using 0.3 μl of
amplified cDNA in a 12.5 μl reaction volume using BIOTAQ
(BIOLINE). GTSF1 primers (Table 1) were designed using
the Primer3 programme (http://primer3.ut.ee/) and derived
from human sequences found in GenBank (GTSF1
AK098819; GAPDH AF261085, NM_144594.2). PCR was
performed for 32 cycles for 45 s at each step of 94, 60, and 72
°C. The housekeeping gene (glyceraldehyde-3-phosphate
Fig. 1 Expression of GTSF1 transcripts in the human female germline,
preimplantation embryos, and adult tissues. a Expression of GTSF1
(primers 7 F and 9R2: Size = 152 base pairs), GAPDH, and FIGLA
gene transcripts by reverse transcription RT-PCR in amplified cDNA
samples derived from human ovarian follicles, oocytes, and granulosa
cells. The FIGLA PCR demonstrates the presence of oocyte cDNA in
the ovarian follicle samples. Lane (1) Primordial follicles (n = 28 pooled
follicles), (2) pooled primordial/early primary follicles (n = 45), (3)
pooled primary follicles (n = 7), and (4) pooled secondary follicles
(n = 7). Lanes (5) to (8) are cDNAs generated from two dissected 5 mm
antral follicles (follicles a and b). Lane (5) Denuded single human GV
stage oocytes isolated from the compact cumulus-enclosed oocyte
complexes of a 5 mm non-luteinised antral follicle (follicle a), lane (6)
granulosa cells isolated from follicle a. Lane (7) Denuded single human
GV stage oocytes isolated from the compact cumulus-enclosed oocyte
complexes of a 5 mm nonluteinised antral follicle (follicle b), lane 8
granulosa cells isolated from follicle b. Lanes (9) and (10) single MII
oocytes, lanes 11 to 16 cDNA from cumulus granulosa cells isolated from
5–10 mm non-luteinised antral follicles containing failed fertilization
metaphase II oocytes. Lanes (17) and (18) are negative PCR controls
(no template, −ve). *Only weak PCR products for FIGLA and GTSF1
were observed in one of the MII oocytes tested in this particular assay
(lane 10). b Expression of GTSF1 (primers 3 F and 7R) and GAPDH in
cDNAs from adult human tissue (Clontech Multiple Tissue cDNA MTC
panels) and controls. Lanes (1) ovary, (2) testis, (3) spleen, (4) prostate,
(5) small intestine, (6) colon, (7) thymus, (8) leukocyte, (9) pooled GV
oocyte (positive control, +ve), (10) negative control (no template, −ve),
and (11) mixed adult human multiple tissue sample. c GTSF1 RT-PCR
(primersGTSF1 real-time F andGTSF1 real-time R), in individual human
oocytes and preimplantation embryos. cDNAs were derived from pooled
metaphase II oocytes (n = 6, lanes 1 to 6), morulae (n = 5, lanes 7–11),
blastocysts (n = 7, lanes 12–18), and a negative control (−ve, no tem-
plate). d GTSF1 RT-PCR covering the entire coding region, from exons
1–9, in cDNAs derived from pooled germinal vesicle (GV) oocytes
(n = 6), metaphase II oocytes (n = 7), blastocysts (n = 7), testis and mixed
adult human multiple tissue samples (MT)
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dehydrogenase) GAPDH was used as a positive control to
demonstrate that the cDNA libraries that were generated from
each sample were successful; GAPDH primers used in Fig. 1
a, b were taken from Weisenberger et al. 2002 [24]. The factor
in the germline alpha (FIGLA) primers was from Huntriss et al.
2002 [17]. Products were run on 1.2 % agarose gels and
visualised using ethidium bromide with reference to 100 base
pair DNA size markers (Life Technologies, Ltd). Expression of
the human GTSF1 gene was also analysed using a range of
normalized cDNA samples derived from various human
tissues (Clontech MTC panels, Clontech).
Sequencing
GTSF1 PCR products that were obtained using various primer
combinations were cloned into TOPO TA (Life Technologies).
Primer sequences are given in Table 1. The M13 primer-
amplified PCR products were sequenced at the Biomolecular
Analysis Facility, University of Leeds. Sequences of PCR
products were obtained in both directions and were identified
by the Basic Local Alignment Search Tool (BLAST)
http://www.ncbi.nlm.nih.gov/BLAST.
Real-time PCR
The real-time PCR reaction data was collected using an ABI
PRISM 7900HT Real-Time PCR system using the SYBR
Green method (Applied Biosystems). PCR primer sequences
are described in Table 1. The 25 μl reaction mix contained
2 ng cDNA, 10 pmol of each primer. The PCR protocol was
denaturation (95 °C for 10 min), amplification (94 °C 10 s,
60 °C 30 s, and 72 °C 30 s for 45 cycles). For quantitative
assessment ofGTSF1 expression in the female germline, real-
time PCR was performed on cDNA derived from primordial
follicles, primordial/early primary follicles, primary follicles,
secondary follicles, pooled cDNA from germinal vesicle (GV)
stage oocytes (n = 8), pooledmetaphase II oocytes (n = 8), and
commercially available ovary and testis RNA (FirstChoice
RNA, Ambion). Each sample was assessed in triplicate.
Data are expressed as a percentage of the housekeeping gene
GAPDH using the formula 2−ΔCT × 100, in which CT is the
threshold cycle number. For real-time PCR analysis ofGTSF1
expression in human fetal ovary and testis experiments were
performed as described previously [25], with the equivalent of
approximately 2.5 ng of cDNA used per reaction in 10 μl
reaction volumes. Significant changes in expression across
gestation were determined by one-way ANOVA with
Tukey’s Multiple Comparison Test (GraphPadPrism 5.0 soft-
ware). Due to the limiting amounts of cDNA that were avail-
able for ovarian follicle samples and human fetal gonads, we
were unfortunately unable to assess further housekeeping
genes across this series of samples as controls.
Results
Isolation and expression of GTSF1
A partial sequence of the GTSF1 gene was originally isolated
during differential display analysis from cDNAs derived from
staged human ovarian follicles (J Huntriss, D Miller, HM
Picton unpublished data). BLASTsearches with this sequence,
that were performed prior to the release of the GSTF1 gene
Table 1 PCR primers for
conventional and real-time PCR Gene Primer name Sequence 5′ to 3′
GTSF1 Exon1F GGAGGAAGGTGACTGTGAGG
Exon2F CACTTGGATTCAGCTTCTTC
Exon3F GACCCTGAGAAGCTATTGCA
Exon7F CCCTGCGAGCAACATAGTTA
Exon7R TAACTATGTTGCTCGCAGGG
Exon9R CTGTATCAAAGGTTTATTTGGAAGC
GTSF1 real-time F ATTCAGCTTCTTCATTTCCAACA
GTSF1 real-time R CCTGATTTGATGGTTTTTGTCAT
FIGLA FIGLA F1* GATAAAAAATCTCAACCGTGG
FIGLA R1* CCCTCCTCTTCTTTCTTC
GAPDH GAPDH F§ ACGGGAAGCTCACTGGCATGGC
GAPDH R§ TCTTACTCCTTGGAGGCCATGTAGG
GAPDH real-time F TTGTCAAGCTCATTTCCTGGTAT
GAPDH real-time R TCTCTCTTCCTCTTGTGCTCTTG
*FIGLA primers are from Huntriss et al. [17]
§GAPDH primers are from Weisenberger et al. [24]
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sequence (for any species) in any gene database, initially iden-
tified a 100 % match over 138 nucleotides of readable se-
quence to the human sequences AK057504 and AK098819,
both testis-derived transcripts. On translation, the partial se-
quence exhibited similarity to the Xenopus D7 oocyte protein
that is represented by P13007 and NP_001081517 protein se-
quences. The human sequence was chosen for further study by
virtue of the fact that it likely represented a novel human oo-
cyte transcript with sequence similarity to the Xenopus D7
protein gene. Analysis by reverse transcription (RT)-PCR with
gene-specific primers encompassing the partial sequence from
AK057504 in samples derived from the adult human female
germline indicated a pattern of expression consistent with be-
ing derived from oocytes (Fig. 1a). Figure 1a shows that
amplicons were generated in ovarian follicle cDNAs (primor-
dial through to secondary stages), germinal vesicle-stage (GV)
oocytes, and metaphase II (MII) oocytes, and therefore in the
same samples that we detected transcripts of FIGLA, another
transcript observed in oocytes [17].
Subsequent BLAST searches identified the partial sequence
as a fragment of novel gene, FAM112B (family with sequence
similarity 112 member B) mapping to chromosome12q13.2.
The FAM112B gene encodes a member of an uncharacterized
protein family containing a conserved protein domain UPF0224.
The gene has been more recently assigned the approved name
Gametocyte-specific factor 1 and symbol (GTSF1), (GeneID:
121355, Ensembl gene ENSG00000170627). We performed
further characterisation of the expression of GTSF1 using
primers designed from exons predicted in current GTSF1
mRNA sequence NM_144594.2 and the related testis-derived
mRNA sequences (AK057504 and AK098819) that pre-dated
the NM_144594.2 sequence submission. Expression of GTSF1
was examined across a range of normalized human cDNA sam-
ples utilizing primers from exons 3 and 7 of NM_144594.2
(Fig. 1b) and revealed expression in the ovary, testis, spleen
thymus, and in the positive controls (cDNA from pooled GV
oocytes (lane 9) and mRNA from multiple-tissues (lane 11).
Expression of GTSF1 transcripts was also assessed in a series
of individual MII oocytes and in preimplantation embryos
(Fig. 1c).GTSF1 expression was observed in all tested samples:
six additional single human MII oocytes, five morulae, and sev-
en blastocysts. A PCR assay covering the entire coding region
was designed upon the release of the NM_144594.2 sequence,
utilizing primers designed from GTSF1 exons 1 and 9. This
assay amplified the appropriate-sized PCR product in samples
of pooled GVoocytes, pooled MII oocytes, pooled blastocysts,
testis, and mixed human adult tissues (Fig. 1d). In addition, a
second smaller transcript was observed in blastocysts.
GTSF1 gene and protein sequence
Human GTSF1 gene cDNA clones that were obtained from
human oocytes and blastocysts were sequenced and data is
shown in Supplemental Figure 1. This experimentally-
defined transcript sequence spans the entire coding region se-
quence from exon 1 to 9 and the isolated sequence, and its
translation, are in full agreement with the sequences
NM_144594.2 and NP_653195 and the gene structure as rep-
resented by Ensembl GTSF1-001 splice variant that contains 9
exons (Transcript ID: ENST00000305879). The two CHHC
zinc-finger domains (TRM13/UPF0224_CHHC_Znf_dom)
are identified in Supplemental Figure 1. In blastocysts, the
smaller transcript identified in Fig. 1d, that lacks exon 3, most
likely represents the GTSF1-004 transcript (Transcript ID:
OTTHUMT00000406189), a processed transcript that has no
protein product and matches to ESTs (602638807 F1,
602552556 F1) that are derived frommucoepidermoid carcino-
ma and embryonal carcinoma, respectively. TheGTSF1 cDNA
sequences that were isolated from the PCR products shown in
Fig. 1d, were subsequently aligned on the browser
(Supplemental Figure 2) using the BLAT tool on the UCSC
browser (https://genome.ucsc.edu/FAQ/FAQblat.html). Shown
are the blastocyst-specific GTSF1 transcript variant lacking ex-
on 3 (Track 1), the GTSF1 transcript sequence as isolated from
oocytes, blastocysts and all other stages of oogenesis and pre-
implantation development (Track 2) and the UCSC gene (com-
piled from RefSeq, GenBank and other sources-Track 3).
Real-time PCR analysis of GTSF1 expression
in human fetal gonads and the adult female germline
Quantitative measurement of GTSF1 expression was deter-
mined by real-time PCR relative to the housekeeping control
gene GAPDH. GTSF1 expression was assessed in the human
fetal ovary and in the human fetal testis at gestations of 8–
11 weeks, 14–16 weeks, and 17–21 weeks, using 4–5 samples
per group (Fig. 2a). Over these periods, GTSF1 expression
was observed to increase in both the ovary and testis.
Significant changes in expression across gestation were deter-
mined by one-way ANOVA with Tukey’s Multiple
Comparison Test (GraphPadPrism 5.0 software). Thus, ovary
fold changes were 8–11 weeks vs. 14–16 weeks: 4-fold in-
crease (P < 0.01) and 8–11 week vs. 17–21 weeks, 6.4-fold
increase (P < 0.001) and 14–16 weeks vs. 17–21 weeks, and
1.6-fold increase (P < 0.01). Testis fold changes were 8–
9 weeks vs. 14–16 weeks, 5.8-fold increase (not significant),
8–9 weeks vs. 17–19 weeks, 17.4-fold increase (P < 0.01) and
14–16 weeks vs. 17–19 weeks, and 3-fold increase (P < 0.05).
Next, the expression of GTSF1 during the ovarian follicle
growth phase and final stages of oocytematuration in the adult
female ovary was approximated with a series of archived
cDNAs [17] from the female germline that included staged
ovarian follicles (primordial, primordial/early primary, prima-
ry follicles, and secondary follicles) and also included pooled
cDNAs derived from GV-staged oocytes and MII oocytes
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(Fig. 2b). For comparison, cDNAs derived from adult human
ovary and testis were included.GTSF1 expression was detect-
ed in all ovarian follicles, and germinal vesicle-stage oocytes
and metaphase II oocytes with the highest expression relative
to GAPDH observed in germinal vesicle-stage oocytes.
Finally, real-time PCR was performed using the same range
of cDNA samples from adult human tissue as shown in Fig. 1b
to reveal that expression of GTSF1 was highest in the testis
(Fig. 2c).
Conclusions
In this report, we have described the expression of the human
GTSF1 gene from cDNAs derived from fetal gonads, adult
human ovarian follicles, GV oocytes, metaphase II oocytes,
and preimplantation embryos. The mainGTSF1 transcript iso-
lated from oocytes and preimplantation embryos corresponds
to the GTSF1-001 transcript variant of GTSF1 that encodes a
167 amino acid protein. GTSF1 is a highly conserved gene
that maps to 12q13.2 and has 91 % identity between the
mouse and human proteins in agreement with earlier studies
[1, 3, 26], with the high conservation indicative of a common
function across species.
In cDNAs derived from ovarian follicles that were isolated
from the adult ovary, transcripts of GTSF1 are detected from
the primordial follicle stage and are expressed through to the
metaphase II oocyte stage. Real-time PCR revealed that
highest expression was observed in GV oocytes, with a sub-
sequent decrease in MII oocytes, in agreement with data for
mouse Gtsf1 gene transcripts (http://www.ncbi.nlm.nih.
gov/geoprofiles/29792642). Our PCR expression data
reveals that GTSF1 is also expressed during human
preimplantation development, being detected in late
preimplantation embryos. These observations indicate that
expression is activated after zygotic gene activation, and this
was supported by our observation of a blastocyst-specific tran-
script variant of GTSF1 lacking exon 3. Our expression data
for mature oocytes and preimplantation embryos are consis-
tent with that described in the Human Embryo Resource
HumER [27]. Our expression data for somatic tissues is con-
sistent with microarray and RNAseq data from other sources
Fig. 2 Real-time PCR assessment of GTSF1 expression. Real-time PCR
assessment of GTSF1 expression is expressed as a percentage of the
housekeeping gene GAPDH and using primers GTSF1 real-time F and
R and GAPDH real-time F and R. a GTSF1 expression in human fetal
ovaries at different stages of gestation (total tested range was between 8
and 21 weeks) that were grouped into 8–11 weeks, 14–16weeks, and 17–
21 weeks of gestation, n = 4–5 samples per group. Bars indicate mean ±
sem. b GTSF1 expression in human fetal testis at different stages of
gestation (total tested range was between 8 and 19 weeks) that were
grouped into 8–9 weeks, 14–16 weeks, and 17–19 weeks of gestation,
n = 4 samples per group. c GTSF1 expression by real-time PCR in
cDNAs from human ovarian follicles (follicle number per sample as
described in Fig. 1a) and pooled germinal vesicle (GV) oocytes (n = 8),
pooled metaphase II oocytes (n = 8), and adult gonads. Samples left to
right: primordial follicles, primordial/early primary follicles, primary fol-
licles, secondary follicles, pooled cDNA from germinal vesicle (GV)
stage oocytes (n = 8), pooled metaphase II oocytes (n = 8), human ovary
(Ambion), and human testis (Ambion). d GTSF1 expression by real-time
PCR in cDNAs from human adult human tissue (Clontech Multiple
Tissue cDNA panels, tissues as shown in Fig. 1b) and controls
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that indicate highest expression of theGTSF1 transcripts with-
in adult tissues occurs in the testis (http://biogps.org/ and
http://www.ebi.ac.uk/). Our expression data for oocytes and
preimplantation embryos is consistent with microarray data
from http://www.ncbi.nlm.nih.gov/geoprofiles (geoprofile
IDs 74253766 and 52847566). We were unable to perform
analysis of the expression GTSF1 protein in our laboratory;
however, GTSF1 protein expression has been described by the
Human Protein Atlas ([28]: http://www.proteinatlas.
org/ENSG00000170627-GTSF1/tissue). In agreement with our
data for the GTSF1 transcript, this resource reveals that GTSF1
protein (and RNA) expression is largely exclusive to the male
and female reproductive tissues. Protein expression is described
as being medium in ovarian follicles (but undetectable in
ovarian stroma) enriched in the testis, but weakly expressed or
undetectable in any other adult human tissues.
Here, we have reported for the first time the elevation of
expression of GTSF1 gene transcripts at the time of entry into
meiosis and subsequent primordial follicle formation in the
human fetal ovary. This may suggest a particular requirement
for GTSF1 during ovarian programming and early oogenesis
and also in GVoocytes in particular. In themale germ line, there
is now clear evidence that Piwi-mediated retrotransposon sup-
pression is essential for fertility [29–33], and this includes a
requirement for Gtsf1 in this process [7]. Failure to suppress
retrotranposonsmay affect genomic stability and lead to disease
[34–36], and retrotransposons are abundant in germ cells and
preimplantation embryos [37–42]. In contrast to the infertility
observed in Gtsf1-null male mice,Gtsf1-null female mice were
observed to be fertile with no histological abnormalities in the
ovaries [7]. Retrotransposons are known to be silenced in mu-
rine primordial ovarian follicles via a piRNA-dependent mech-
anism, and this is believed to occur in nuage-like structures in
the oocytes of primordial follicles [43]. However, mice with
nuage-mutant primordial follicles defective for Mvh, Mili, or
Gasz remain fertile, despite elevated transposon expression
[43]. These studies, which reflect the observations of male-
specific sterility vs. female fertility in Gtsf1-null mice [7], sug-
gest that the PIWI-pathway in isolation may not be critical for
female fertility. Retrotransposon suppression, at least that which
is critical for female fertility, may be regulated in the mamma-
lian female germ line by Meiosis arrest female 1 (MARF1) and
accordingly, Marf1 mutant females are infertile [44, 45].
We acknowledge that there are a number of shortcomings in
our study. Firstly, for some of the samples, particularly the hu-
man ovarian follicles and fetal gonads, we were unable to obtain
real-time PCR data for additional housekeeping genes across all
stages because of the extremely limiting amounts of cDNA that
were available to us. Accordingly, the real-time expression data
is only normalised to one housekeeping gene, GAPDH.
Secondly, we were only able to obtain ovarian follicles from a
single patient for this study and therefore, we are not able to
confirm whether the GTSF1 transcript expression patterns
observed here are representative of the patterns that would be
observed in a wider range of samples from different patients.
Currently, the role ofGTSF1 during mammalian oogenesis
remains unclear. The function of GTSF1/Gtsf1 has also been
investigated by bioinformatic analysis which has revealed that
the two U11-48 K-like CHHC-type zinc finger domains
(Pfam: PF05253) within the human GTSF1 protein are found
in spliceosomal proteins and tRNA modifying enzymes are
predicted to have an RNA binding function [26, 46]. Indeed,
the CHHC zinc-finger domain has been observed to specifi-
cally bind the 5′ splice site of U12-type introns in
spliceosomal U11-48 K proteins [46]. We hypothesize how-
ever that although Gtsf1 appears dispensable for female fertil-
ity in mice [7], the retention of the expression ofGTSF1/Gtsf1
in the female germline across several species including mouse
[1, 3], human (this report), and bovine and ovine oocytes
(H.M.Picton, J.Huntriss, J.Lu, G.Liperis- unpublished data,
[47, 48]) is indicative of a retained function in the mammalian
oocyte and/or early embryo. Of particular interest, the abun-
dance of the GTSF1 protein in murine MII oocytes was ob-
served to be significantly reduced upon postovulatory-ageing
[49]; however, further experiments are required to understand
the role of this gene in the mammalian oocyte.
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